Cargando…

Triple mapping for axillary staging after neoadjuvant therapy: Axillary reverse mapping with indocyanine green and dual agent sentinel lymph node biopsy

Axillary staging is 1 of the major issues of current breast cancer management after neoadjuvant systemic therapy (NST). Sentinel lymph node biopsy (SLNB) is an option for clinically node negative patients. Axillary reverse mapping (ARM) was introduced to identify and preserve the lymphatic drainage...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tasdoven, Ilhan, Balbaloglu, Hakan, Erdemir, Rabiye Uslu, Bahadir, Burak, Guldeniz Karadeniz, Cakmak
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	5750
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9803496/ https://www.ncbi.nlm.nih.gov/pubmed/36596061 http://dx.doi.org/10.1097/MD.0000000000032545

Ejemplares similares

Can inflammatory indices predict sentinel lymph node status in patients with early-stage breast cancer?
por: Balbaloglu, Hakan, et al.
Publicado: (2023)

Predicting coexisting thyroid cancer with primary hyperparathyroidism in an endemic region of multinodular goiter: evaluating the effectiveness of preoperative inflammatory markers
por: Balbaloglu, Hakan, et al.
Publicado: (2023)

Lymphoscintigraphy in patients with breast cancer-related lymphedema after sentinel lymph node dissection and axillary radiation therapy
por: Oh, Se Hyun, et al.
Publicado: (2022)

Is pre-operative axillary ultrasound alone sufficient to determine need for axillary dissection in early breast cancer patients?
por: Jamaris, Suniza, et al.
Publicado: (2021)

Clinical study of combined application of indocyanine green and methylene blue for sentinel lymph node biopsy in breast cancer
por: Zhang, Chenguang, et al.
Publicado: (2021)

Successful use of minimal invasive debridement plus negative pressure wound therapy under skin flap and axillary region for refractory postmastectomy seroma: A STROBE-compliant retrospective study
por: Esen, Ebru, et al.
Publicado: (2022)

Male occult breast cancer with axillary lymph node metastasis as the first manifestation: A case report and literature review
por: Xu, Ruixin, et al.
Publicado: (2017)

Randomized controlled trial of late-course concurrent versus sequential chemoradiotherapy after mastectomy and axillary surgery in locally advanced breast cancer
por: Lu, Ying, et al.
Publicado: (2017)

Volume-based metabolic parameter of breast cancer on preoperative (18)F-FDG PET/CT could predict axillary lymph node metastasis
por: An, Young-Sil, et al.
Publicado: (2017)

Management of the axilla with sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer: A single-center study
por: Aksoy, Suleyman Ozkan, et al.
Publicado: (2020)

The Extent of Axillary Surgery Is Associated With Breast Cancer-specific Survival in T1–2 Breast Cancer Patients With 1 or 2 Positive Lymph Nodes: A SEER-Population Study
por: Li, Shunrong, et al.
Publicado: (2016)

High expression of MORC2 predicts worse neoadjuvant chemotherapy efficacy in triple negative breast cancer
por: Liao, Xiaohong, et al.
Publicado: (2023)

Comparison of indocyanine green and methylene blue use for axillary reverse mapping during axillary lymph node dissection
por: Wu, Jun‐Dong, et al.
Publicado: (2020)

Preoperative predictive factors affecting sentinel lymph node positivity in breast cancer and comparison of their effectiveness with existing nomograms
por: Ceylan, Cengiz, et al.
Publicado: (2022)

Targeted axillary biopsy and sentinel lymph node biopsy for axillary restaging after neoadjuvant chemotherapy
por: Gurleyik, Gunay, et al.
Publicado: (2021)

Relationship between perimetric increase and fluoroscopic pattern type in secondary upper limb lymphedema observed by Indocyanine green lymphography
por: Medina-Rodríguez, María Elena, et al.
Publicado: (2020)

The interplay between hospital and surgeon factors and the use of sentinel lymph node biopsy for breast cancer
por: Yen, Tina W.F., et al.
Publicado: (2016)

Prediction of nodal staging in breast cancer patients with 1-2 sentinel nodes in the Z0011 era
por: Corsi, Fabio, et al.
Publicado: (2020)

Application of neoadjuvant chemotherapy in occult breast cancer: Five case reports
por: Yang, Haisong, et al.
Publicado: (2017)

Prognostic value of IMP3 immunohistochemical expression in triple negative breast cancer
por: Sjekloča, Nikoleta, et al.
Publicado: (2020)

Clinicopathologic features of single bone metastasis in breast cancer
por: Karatas, Murat, et al.
Publicado: (2021)

Changes in HER2 status and survival outcomes in patients with non-pathological complete response after neoadjuvant targeted treatment
por: Ren, Xiaofei, et al.
Publicado: (2023)

Neoadjuvant chemotherapy combined with endocrine therapy for hormone receptor-positive breast cancer: A systematic review and meta-analysis
por: Ma, Hong-Fang, et al.
Publicado: (2023)

MicroRNAs in the prognosis of triple-negative breast cancer: A systematic review and meta-analysis
por: Lü, Lingshuang, et al.
Publicado: (2017)

Value of Breast Cancer Molecular Subtypes and Ki67 Expression for the Prediction of Efficacy and Prognosis of Neoadjuvant Chemotherapy in a Chinese Population
por: Wang, Jiayu, et al.
Publicado: (2016)

Neoadjuvant chemotherapy reduces the expression rates of ER, PR, HER2, Ki67, and P53 of invasive ductal carcinoma
por: Peng, Jian-Heng, et al.
Publicado: (2019)

Background Parenchymal Enhancement on Preoperative Magnetic Resonance Imaging: Association With Recurrence-Free Survival in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy
por: Choi, Ji Soo, et al.
Publicado: (2016)

Features of triple-negative breast cancer: Analysis of 38,813 cases from the national cancer database
por: Plasilova, Magdalena L., et al.
Publicado: (2016)

Ki-67 labeling index is a predictive marker for a pathological complete response to neoadjuvant chemotherapy in breast cancer: A meta-analysis
por: Tao, Miaomiao, et al.
Publicado: (2017)

Rare metastasis to paranasal sinuses from triple-negative breast cancer: A case report and literature review
por: Xiong, Jie, et al.
Publicado: (2017)

Hypoxia-mediated activation of hypoxia-inducible factor-1α in triple-negative breast cancer: A review
por: Liu, Lihui, et al.
Publicado: (2023)

Elevated expression of MTDH predicts better prognosis of locally advanced HER-2 positive breast cancer patients receiving neoadjuvant chemotherapy plus trastuzumab
por: Wang, Xinle, et al.
Publicado: (2019)

Prognostic value of long non-coding RNAs in triple negative breast cancer: A PRISMA-compliant meta-analysis
por: Zhang, Shuo, et al.
Publicado: (2020)

Combination of Chinese medicinal formulas and chemotherapy for triple-negative breast cancer strengthens body resistance to eliminate pathogenic factors
por: Zhang, Yiyi, et al.
Publicado: (2022)

Apatinib + CPT-11 + S-1 for treatment of refractory brain metastases in patient with triple-negative breast cancer: Case report and literature review
por: Hu, Ting, et al.
Publicado: (2018)

Can we cure stage IV triple-negative breast carcinoma?: Another case report of long-term survival (7 years)
por: Chue, Ben Man-Fai, et al.
Publicado: (2019)

Prediction of postoperative survival of triple-negative breast cancer based on nomogram model combined with expression of HIF-1α and c-myc
por: Cui, Jianxiu, et al.
Publicado: (2019)

Social isolation and cancer management after the 2011 triple disaster in Fukushima, Japan: A case report of breast cancer with patient and provider delay
por: Ozaki, Akihiko, et al.
Publicado: (2016)

Expression analysis of E-cad and vascular endothelial growth factor in triple-negative breast cancer patients of different ethnic groups in western China
por: Jiang, Weihua, et al.
Publicado: (2017)

Pathological complete response to neoadjuvant trastuzumab and pertuzumab therapy is related to human epidermal growth factor receptor 2 (HER2) amplification level in HER2-amplified breast cancer
por: Choi, Jin Hyuk, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_alu2bkf6oh98hqkb80n506h16i